Electronic nicotine delivery systems (ENDS) aerosol constituent deposition and nicotine retention in the human oral cavity.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
asgharian (2023)
Simulation Modeling of air and Droplet Temperatures in the human Respiratory Tract for Inhaled Tobacco Products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
asgharian (2023)
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Azzopardi (2022)
Respiratory Tract Deposition of E-Cigarette Particles.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Bennett (2022)
What factors reliably predict electronic cigarette nicotine delivery?
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Blank (2020)
Electromembrane extraction of nicotine in inhaled aerosols from tobacco cigarettes, electronic cigarettes, and heated tobacco products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Chen (2022)
E-liquid alters oral epithelial cell function to promote epithelial to mesenchymal transition and invasiveness in preclinical oral squamous cell carcinoma.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
de Lima (2023)
Sensory experiences and cues among E-cigarette users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
DiPiazza (2020)
a randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ebajemito (2020)
Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and na"ive users (smokers)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Farsalinos (2015)